SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000944809-22-000018
Filing Date
2022-05-02
Accepted
2022-05-02 16:18:20
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A opk-20211231.htm   iXBRL 10-K/A 427807
2 EX-31.1 opk-12312021xex311ka.htm EX-31.1 3519
3 EX-31.2 opk-12312021xex312ka.htm EX-31.2 3559
  Complete submission text file 0000944809-22-000018.txt   721329

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20211231.xsd EX-101.SCH 2528
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20211231_lab.xml EX-101.LAB 40962
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20211231_pre.xml EX-101.PRE 21636
9 EXTRACTED XBRL INSTANCE DOCUMENT opk-20211231_htm.xml XML 21554
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33528 | Film No.: 22882213
SIC: 2834 Pharmaceutical Preparations